Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms

Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms

Abstract Background Oncolytic virotherapy is an upcoming treatment option for many tumor entities. But so far, a first oncolytic virus only was approved for advanced stages of malignant melanomas. Neuroendocrine tumors (NETs) constitute a heterogenous group of tumors arising from the neuroendocrine...

Full description

Bibliographic Details
Main Authors: Linus D. Kloker, Susanne Berchtold, Irina Smirnow, Julia Beil, Andreas Krieg, Bence Sipos, Ulrich M. Lauer
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cancer
Subjects:
Endocrine cancers
Virotherapy
Immunotherapy
Vaccinia virus
Neuroendocrine tumors
Online Access:http://link.springer.com/article/10.1186/s12885-020-07121-8

Internet

http://link.springer.com/article/10.1186/s12885-020-07121-8

Similar Items